283 related articles for article (PubMed ID: 25996068)
1. Target-based molecular modeling strategies for schistosomiasis drug discovery.
Ferreira LG; Oliva G; Andricopulo AD
Future Med Chem; 2015; 7(6):753-64. PubMed ID: 25996068
[TBL] [Abstract][Full Text] [Related]
2. How has the genomics era impacted schistosomiasis drug discovery?
Oliveira G; Pierce RJ
Future Med Chem; 2015; 7(6):685-7. PubMed ID: 25996060
[No Abstract] [Full Text] [Related]
3. Schistosome sirtuins as drug targets.
Lancelot J; Cabezas-Cruz A; Caby S; Marek M; Schultz J; Romier C; Sippl W; Jung M; Pierce RJ
Future Med Chem; 2015; 7(6):765-82. PubMed ID: 25996069
[TBL] [Abstract][Full Text] [Related]
4. Drugging the schistosome zinc-dependent HDACs: current progress and future perspectives.
Marek M; Oliveira G; Pierce RJ; Jung M; Sippl W; Romier C
Future Med Chem; 2015; 7(6):783-800. PubMed ID: 25996070
[TBL] [Abstract][Full Text] [Related]
5. Schistosomiasis and its treatment.
Caffrey CR
Future Med Chem; 2015; 7(6):675-6. PubMed ID: 25996057
[No Abstract] [Full Text] [Related]
6. Repurposing pharma assets: an accelerated mechanism for strengthening the schistosomiasis drug development pipeline.
Ramamoorthi R; Graef KM; Dent J
Future Med Chem; 2015; 7(6):727-35. PubMed ID: 25996066
[TBL] [Abstract][Full Text] [Related]
7. Schistosomiasis Drug Discovery in the Era of Automation and Artificial Intelligence.
Moreira-Filho JT; Silva AC; Dantas RF; Gomes BF; Souza Neto LR; Brandao-Neto J; Owens RJ; Furnham N; Neves BJ; Silva-Junior FP; Andrade CH
Front Immunol; 2021; 12():642383. PubMed ID: 34135888
[TBL] [Abstract][Full Text] [Related]
8. Using an open source model to accelerate schistosomiasis drug research.
Todd MH; Coaker H
Future Med Chem; 2015; 7(6):689-92. PubMed ID: 25996061
[No Abstract] [Full Text] [Related]
9. Searching for drugs for Chagas disease, leishmaniasis and schistosomiasis: a review.
Santos SS; de Araújo RV; Giarolla J; Seoud OE; Ferreira EI
Int J Antimicrob Agents; 2020 Apr; 55(4):105906. PubMed ID: 31987883
[TBL] [Abstract][Full Text] [Related]
10. Schistosomiasis: Drugs used and treatment strategies.
Siqueira LDP; Fontes DAF; Aguilera CSB; Timóteo TRR; Ângelos MA; Silva LCPBB; de Melo CG; Rolim LA; da Silva RMF; Neto PJR
Acta Trop; 2017 Dec; 176():179-187. PubMed ID: 28803725
[TBL] [Abstract][Full Text] [Related]
11. What is the mechanism of action of praziquantel and how might resistance strike?
Cupit PM; Cunningham C
Future Med Chem; 2015; 7(6):701-5. PubMed ID: 25996063
[No Abstract] [Full Text] [Related]
12. The evolution of drugs on schistosoma treatment: looking to the past to improve the future.
da Rocha Pitta MG; da Rocha Pitta MG; de Melo Rêgo MJ; Galdino SL
Mini Rev Med Chem; 2013 Apr; 13(4):493-508. PubMed ID: 23373654
[TBL] [Abstract][Full Text] [Related]
13. Discovery of Novel Antischistosomal Agents by Molecular Modeling Approaches.
Mafud AC; Ferreira LG; Mascarenhas YP; Andricopulo AD; de Moraes J
Trends Parasitol; 2016 Nov; 32(11):874-886. PubMed ID: 27593339
[TBL] [Abstract][Full Text] [Related]
14. Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis.
Doenhoff MJ; Cioli D; Utzinger J
Curr Opin Infect Dis; 2008 Dec; 21(6):659-67. PubMed ID: 18978535
[TBL] [Abstract][Full Text] [Related]
15. Molecular Context of ADP-ribosylation in Schistosomes for Drug Discovery and Vaccine Development.
Chutshela A; Masamba P; Oyinloye BE; Kappo AP
Curr Drug Discov Technol; 2021; 18(4):473-484. PubMed ID: 32767945
[TBL] [Abstract][Full Text] [Related]
16. Structure-Based Study of Natural Products with Anti-Schistosoma Activity.
Akachukwu I; Olubiyi OO; Kosisochukwu A; John MC; Justina NN
Curr Comput Aided Drug Des; 2017; 13(2):91-100. PubMed ID: 28103771
[TBL] [Abstract][Full Text] [Related]
17. Schistosomiasis therapeutics: whats in the pipeline?
Trainor-Moss S; Mutapi F
Expert Rev Clin Pharmacol; 2016; 9(2):157-60. PubMed ID: 26508363
[TBL] [Abstract][Full Text] [Related]
18. Praziquantel for Schistosomiasis: Single-Drug Metabolism Revisited, Mode of Action, and Resistance.
Vale N; Gouveia MJ; Rinaldi G; Brindley PJ; Gärtner F; Correia da Costa JM
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28264841
[TBL] [Abstract][Full Text] [Related]
19. Alternatives to Praziquantel for the Prevention and Control of Schistosomiasis.
Spangenberg T
ACS Infect Dis; 2021 May; 7(5):939-942. PubMed ID: 32819092
[TBL] [Abstract][Full Text] [Related]
20. Repurposing apoptosis-inducing cancer drugs to treat schistosomiasis.
Lee EF; Fairlie WD
Future Med Chem; 2015; 7(6):707-11. PubMed ID: 25996064
[No Abstract] [Full Text] [Related]
[Next] [New Search]
